Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Drouet

Showing results (101-110 of 174) with videos related to

Pageof 18
Sort By:
Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology|August 1, 1977
Splanchnic blood flow, O2 consumption, removal of lactate, and output of glucose in highlandersA Capderou, J Polianski, J Mensch-Dechene, et al.
Pathologie-Biologie|February 15, 2005
[Blood activation during long-term mechanical circulatory support]M Kirsch, E Vermes, B Boval, et al.
Clinical Hemorheology and Microcirculation|September 19, 1998
Erythrocyte hyperaggregation and thrombogenic dysfibrinogenemiaF Nguyen, L Drouet, M Boisseau, et al.
Nucleic Acids Research|February 11, 1988
A simple and efficient method for isolating high molecular weight DNA from mammalian spermB R Bahnak, Q Y Wu, L Coulombel, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 14, 2000
High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapyA Kéreveur, J Callebert, M Humbert, et al.
The British Journal of Nutrition|April 1, 1995
Characterization of an antithrombotic peptide from kappa-casein in newborn plasma after milk ingestionB Chabance, P Jollès, C Izquierdo, et al.
The Journal of Pediatrics|July 1, 1987
Absence of plasma prostacyclin stimulating activity deficiency in hemolytic uremic syndromeN Schlegel, J Maclouf, C Loirat, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1996
[What are the criteria for choosing a model for evaluating arterial antithrombotic therapy?]P André, C Bal dit Sollier, M Bonneau, et al.
Haemostasis|October 1, 1996
Which experimental model to choose to study arterial thrombosis and evaluate potentially useful therapeutics?P Andre, C Bal dit Sollier, M Bonneau, et al.
Journal of Dairy Science|January 1, 1993
Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activitiesA M Fiat, D Migliore-Samour, P Jollès, et al.
Pageof 18

Showing results (101-110 of 174) with videos related to

Sort By:
Pageof 18
Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology|August 1, 1977
Splanchnic blood flow, O2 consumption, removal of lactate, and output of glucose in highlandersA Capderou, J Polianski, J Mensch-Dechene, et al.
Pathologie-Biologie|February 15, 2005
[Blood activation during long-term mechanical circulatory support]M Kirsch, E Vermes, B Boval, et al.
Clinical Hemorheology and Microcirculation|September 19, 1998
Erythrocyte hyperaggregation and thrombogenic dysfibrinogenemiaF Nguyen, L Drouet, M Boisseau, et al.
Nucleic Acids Research|February 11, 1988
A simple and efficient method for isolating high molecular weight DNA from mammalian spermB R Bahnak, Q Y Wu, L Coulombel, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 14, 2000
High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapyA Kéreveur, J Callebert, M Humbert, et al.
The British Journal of Nutrition|April 1, 1995
Characterization of an antithrombotic peptide from kappa-casein in newborn plasma after milk ingestionB Chabance, P Jollès, C Izquierdo, et al.
The Journal of Pediatrics|July 1, 1987
Absence of plasma prostacyclin stimulating activity deficiency in hemolytic uremic syndromeN Schlegel, J Maclouf, C Loirat, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1996
[What are the criteria for choosing a model for evaluating arterial antithrombotic therapy?]P André, C Bal dit Sollier, M Bonneau, et al.
Haemostasis|October 1, 1996
Which experimental model to choose to study arterial thrombosis and evaluate potentially useful therapeutics?P Andre, C Bal dit Sollier, M Bonneau, et al.
Journal of Dairy Science|January 1, 1993
Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activitiesA M Fiat, D Migliore-Samour, P Jollès, et al.
Pageof 18